Iambic’s cutting-edge AI-driven platform tackles the most challenging design problems in drug discovery, addressing unmet patient need. Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinic with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai.

Our physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Exploring multiple profiles in parallel ensures that we design molecules to solve the right problems in disease biology. Our AI-driven platform deeply explores chemical space, revealing novel mechanisms of action and delivering diverse high-quality leads. We are unlocking the untapped potential of known targets and transforming seemingly undruggable targets into opportunities for breakthrough treatments.